Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics

2003273 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Journal of Allergy and Clinical Immunology

Volume 111, Issue 4, pp. 714-719

Field-Weighted Citation Impact: 6.46